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Abstract— The special session “Data Science in 
Computational Psychiatry and Psychiatric Research” at the 5th 
IEEE International Conference on Data Science and Advanced 
Analytics in Turin, Italy, 2018, presents papers specifically 
addressing psychiatric research and computational approaches 
in psychiatry. In this overview, we describe the challenges of 
psychiatric research and computational psychiatry and 
demonstrate how the presented papers approach some of the 
problems of interest.  
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Psychiatric research entered the age of big data with 
patient databases now available with thousands of clinical, 
demographical, social, environmental, neuroimaging, 
genomic, proteomic and other -omic measures. The analysis 
of big data is essential for precision medicine, “an emerging 
approach for treatment and prevention that takes into account 
each person’s variability in genes, environment, and lifestyle” 
[1]. Examples of precision medicine include using targeted 
therapies to specific genetic changes which cause individual 
cancer to grow and progress, such as the HER2+ gene cells. 
However, unlike in many other medical and clinical areas, 
psychiatry has not yet benefited from the possibilities of big 
data and modern computer and data science technologies to 
improve diagnostic, monitoring, prognostic and predictive 
technologies which underpin precision medicine [2].  
Evidence-based psychiatric medicine still focuses on 
randomized controlled trials to establish the best treatment for 
the average patient. Clinical trial provides the highest level of 
evidence by preventing selection bias through random 
allocation of patients in either treatment or control group. 
However, this approach ignores statistical heterogeneity and a 
new treatment is applied to all patients. Precision medicine, on 
the other hand, accepts that reality is not homogenous and 
treatments are tailored to the individual. Precision medicine is 
made possible by the provision of “new” data (such as 
Imaging, Omics, patient records, sensors in smartphones, 
wearables and internet and smartphone usage) and high-
performance computing technology that effectively collects, 
processes, stores and analyses “big data”. It is becoming 
increasingly synonymous with “analytical approach of 
prediction modelling” [3].  
Data-driven approaches apply machine and statistical 
learning methods to high-dimensional data to improve 
classification of disease, to predict the likelihood of 
development of a disease, make a prognosis about likely 
course of a clinical condition, predict treatment outcomes or 
improve treatment selection. The use of big data is usually 
discussed in the context of improving medical care but 
preventing disease became increasingly important in recent 
years [4].  
Psychiatry has not yet benefited from the availability of 
big data and clinical prediction modelling application [2, 5]. 
There are only a few clinical prediction models available and 
even these need to be considered preliminary. Why is this the 
case? The analysis of such data is often more challenging than 
in other medical research areas because: 
i. Psychiatrists study traits which are not easily 
measurable; they need to be measured indirectly e.g. by 
questionnaires (Measurement error).    
ii. Although mental disorders typically show a strong 
heritability, genetic variants for most traits account for far less 
than 1% of the variability.  
iii. Susceptibility genes are often common variants 
rather than mutations which does not allow to target specific 
genetic changes as in cancer. 
iv. The definition of a mental disease is often very broad 
and often includes distinct but unknown subcategories, 
different mental health problems have similar phenotypes and 
many mental (and physical) health problems occur together 
(comorbidity).  
v. Patient recruitment is difficult and there is a high 
proportion of drop-out in many studies and patients often do 
not adhere to the treatment.  
vi. Studies using non-random samples with restrictive 
inclusion criteria and self-selection bias or case-healthy 
control studies are often used in psychiatric research. Models 
with good internal validity typically show poor external 
validity and do not generalize to the clinical population.  
vii. Treatment interventions often have several 
interacting components and it is often difficult to measure the 
active ingredients of an intervention (complex interventions).  
viii. Important data such as Electronic Health records of 
mental health patients are typically narrative text or other 
unstructured data types (which would require non-
conventional data analysis technologies such as NLP to take 
full advantage of such data). 
A mental health disorder, like depression, results from a 
range of different biological and environmental causes, and 
the same cause may lead to different disorders in different 
  
people [6]. Concentrating on a gene-centred and symptom-
based classification approach was, therefore, not successful 
and there is a shift towards machine learning and big data 
analysis which aim to identify data-driven types that are 
coherent across symptoms, brain, genes and behaviour, and 
relevant to a clinical outcome such as the risk of relapse or 
response to treatment [7]. This requires a multimodal 
approach that combines cognitive and clinical measures, 
demographics, environmental, social, genetics, brain imaging, 
omics, social media use, real-time physiological data or real-
time symptoms survey data. The development of pipelines to 
acquire, process and merge data from multiple sources into a 
database in ways that allows prompt and reliable exploration 
and analyses of data and subsequent recommendations is a 
challenge, which can be only achieved by the joint effort of 
computer scientists, clinicians, statisticians, patients, carers 
and other stakeholders.  
Computational Psychiatry will play the leading role in the 
development and application of clinical prediction models in 
mental health. However, data-driven approaches are typically 
using “black box” machine learning methods, which do not 
help to understand the development of a mental illness in the 
brain [6,8]. Computational psychiatry also needs to apply 
theory-driven approaches that attempt to model mental 
processes using abstract algorithms. This will provide a better 
understanding between psychiatric symptoms and the 
underlying neurobiological processes and may provide in the 
future new ways of developing treatments or prevention 
programmes. Computational psychiatry has the potential to 
change psychiatry and move it towards a truly personalized 
medicine approach, and our special session should be part of 
this exciting movement. 
The aim of our special session is to promote researchers 
from both academia and industry to participate in this 
workshop to present, discuss, and share the latest findings in 
the field, and exchange ideas that address real-world problems 
with real-world solutions, as well as to discuss future research 
directions and applications, and to identify a set of 
recommendations for future research activities.  
In this special session, papers address a variety of the 
described problems. Data analytics is not only concerned 
about prediction but also to gain an understanding about the 
mechanisms that cause structural and covariation in data. 
Keynote speaker Fionn Murtagh describes how 
correspondence analyses can be used to contextualized 
activity data for general health, depression and demographics. 
Free text is a common problem in mental health research and 
Yuelin Lin and Thomas Atkinson introduce a method to 
summarize such qualitative data automatically using latent 
Dirichlet allocation. Personalized medicine aims to assign the 
best treatment to a patient. Xuan Zhou, Yuanjia Wang and 
Donglin Zeng propose a novel machine learning technique to 
generalize outcome-weighted learning for binary treatment to 
multi-treatment settings via sequential weighted support 
vector machines. High-dimensional datasets with multiple 
categorical variables and missing data are a common 
challenge in psychiatric survey data sets. Constantin 
Ahlmann-Eltze and Christopher Yau propose a new scalable 
Bayesian clustering algorithm to identify low-dimensional 
structures embedded within the high-dimensional dataset of 
categorical data. Comorbidities are a challenge in psychiatric 
research. Maxim Sharaev and his colleagues describe the 
development of an efficient pipeline to investigate 
neuroimaging data as candidate biomarkers for depression, 
and depression and epilepsy comorbidity. 
In conclusion, our special session provides an exciting 
overview of new data science applications in psychiatric 
research. It provides a vision of the near future for the field of 
“precision psychiatry” with the ultimate goal to provide better 
lives for those suffering from mental illness [3]. 
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